World Journal of Traditional Chinese Medicine

REVIEW ARTICLE
Year
: 2020  |  Volume : 6  |  Issue : 3  |  Page : 249--259

Clinical effect of tripterygium glycosides combined with glucocorticoids in the treatment of refractory nephrotic syndrome patients: A systematic review and meta-analysis


Ya-Qing Cheng1, Jing Li1, Hai-Shun Qu1, Xian-Zhi Zhang1, Hai-Li Zhang1, Jing Zhang1, Bo Peng2 
1 Department of Nephroendocrine, Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing, China
2 Department of State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China

Correspondence Address:
Dr. Jing Li
Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing 100700
China

The objective of this study is to evaluate the effectiveness and safety of Tripterygium glycosides combined with glucocorticoids for the treatment of refractory nephrotic syndrome (NS). Computer search of Chinese and English databases, including CNKI, VIP, Wan Fang Database, PubMed, Cochrane Library, Embase, and Sinomed, for randomized controlled trials (RCTs) of Tripterygium glycosides combined with glucocorticoids for refractory NS (RNS) was conducted. Meta-analysis was performed using RevMan5.3. Thirteen RCTs comprising 994 patients were included in the study. Tripterygium glycosides combined with glucocorticoids had a statistical significance on the effective rate (odds ratio [OR] =4.69, 95% confidence interval [CI] 3.29, 6.67, P < 0.00001), 24-h urine protein ( Weighted mean difference (MD) = −0.57, 95% CI [−0.62, −0.51], P < 0.00001), serum albumin (MD = 4.77,95% CI [4.30, 5.24], P < 0.00001), total serum protein (MD = 9.45, 95% CI [8.73, 10.17], P < 0.00001), urea nitrogen (MD = −0.53, 95% CI [−0.90, −0.17], P = 0.005), and serum creatinine (MD = −8.45, 95% CI [−15.32, −1.57], P = 0.02). There was no statistical significance on adverse reactions (OR = 0.68, 95% CI [0.41, 1.12], P = 0.13). Tripterygium glycosides combined with glucocorticoids could improve clinical effective rate, reduce 24-h urine protein, improve serum albumin and total serum protein, and reduce urea nitrogen and serum creatinine levels in patients with RNS. However, the quality of the included literature is poor, and conclusion still needs further verification using larger samples and high-quality randomized, double-blind controlled trials.


How to cite this article:
Cheng YQ, Li J, Qu HS, Zhang XZ, Zhang HL, Zhang J, Peng B. Clinical effect of tripterygium glycosides combined with glucocorticoids in the treatment of refractory nephrotic syndrome patients: A systematic review and meta-analysis.World J Tradit Chin Med 2020;6:249-259


How to cite this URL:
Cheng YQ, Li J, Qu HS, Zhang XZ, Zhang HL, Zhang J, Peng B. Clinical effect of tripterygium glycosides combined with glucocorticoids in the treatment of refractory nephrotic syndrome patients: A systematic review and meta-analysis. World J Tradit Chin Med [serial online] 2020 [cited 2020 Dec 5 ];6:249-259
Available from: https://www.wjtcm.net/article.asp?issn=2311-8571;year=2020;volume=6;issue=3;spage=249;epage=259;aulast=Cheng;type=0